Literature DB >> 14678638

Leishmania and HIV co-infection: dermatological manifestations.

L Puig1, R Pradinaud.   

Abstract

Leishmania species can cause a wide spectrum of cutaneous disease in HIV-positive patients: asymptomatic, localized cutaneous, mucosal, muco-cutaneous, diffuse cutaneous or post-kala-azar leishmaniasis. In such cases, which are usually severely immunocompromised, the leishmanial parasites reach the skin of the human host by dissemination after either a new infection (resulting from the bite of infected sandfly or, probably, the sharing of contaminated syringes by intravenous-drug users) or the re-activation of a latent infection. Recent experience and past observations on the dermatology of leishmaniasis in those with Leishmania/HIV co-infection are reviewed here.

Entities:  

Mesh:

Year:  2003        PMID: 14678638     DOI: 10.1179/000349803225002589

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  13 in total

Review 1.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 2.  PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.

Authors:  Eduard E Zijlstra
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

Review 3.  Leishmaniasis-HIV coinfection: current challenges.

Authors:  José Angelo Lauletta Lindoso; Mirella Alves Cunha; Igor Thiago Queiroz; Carlos Henrique Valente Moreira
Journal:  HIV AIDS (Auckl)       Date:  2016-10-07

4.  Unusual presentation of mucocutaneous leishmaniasis in HIV-infected patient.

Authors:  Anupama Bains; Deepak Vedant; Priyanka Gupta; G R Tegta
Journal:  Indian J Sex Transm Dis AIDS       Date:  2016 Jul-Dec

5.  Diffuse Cutaneous Leishmaniasis in an Immunocompromised Patient Resembling Histoid Hansen's Disease.

Authors:  Asha Kumari; Manisha Balai; Lalit K Gupta; Ashok K Khare; Asit K Mittal; Sharad Mehta
Journal:  Indian Dermatol Online J       Date:  2018 Nov-Dec

Review 6.  The Binomial Parasite-Host Immunity in the Healing Process and in Reactivation of Human Tegumentary Leishmaniasis.

Authors:  Fatima Conceição-Silva; Jessica Leite-Silva; Fernanda N Morgado
Journal:  Front Microbiol       Date:  2018-06-19       Impact factor: 5.640

7.  Deficiency of Leishmania phosphoglycans influences the magnitude but does not affect the quality of secondary (memory) anti-Leishmania immunity.

Authors:  Dong Liu; Ifeoma Okwor; Zhirong Mou; Stephen M Beverley; Jude E Uzonna
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

8.  Immunogenicity of MHC Class I Peptides Derived from Leishmania mexicana Gp63 in HLA-A2.1 Transgenic (HHDII) and BALB/C Mouse Models.

Authors:  H Rezvan; R Rees; Sa Ali
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

9.  The associations of Leishmania major and Leishmania tropica aspects by focusing their morphological and molecular features on clinical appearances in Khuzestan Province, Iran.

Authors:  Adel Spotin; Soheila Rouhani; Parviz Parvizi
Journal:  Biomed Res Int       Date:  2014-09-16       Impact factor: 3.411

10.  Contact dermatitis-like cutaneous leishmaniasis in a Libyan HIV patient.

Authors:  Hamida Al-Dwibe; Aisha Gashout; Abdu-Maged Morogum; Said El-Zubi; Ahmad Amro
Journal:  Parasit Vectors       Date:  2014-08-29       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.